Response to Ray and colleagues: the called-for large clinical trial is already ongoing.
Peura
David
D
Chan
Francis K L
FK
Wilcox
Charles Melbern
CM
Niculescu
Liviu
L
Berger
Manuela
M
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy; D000068579:Celecoxib; D004008:Diclofenac / Q000009:adverse effects*; D006801:Humans; D009853:Omeprazole / Q000627:therapeutic use*; D010437:Peptic Ulcer / Q000139:chemically induced / Q000517:prevention & control*; D011720:Pyrazoles / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D013449:Sulfonamides / Q000009:adverse effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents; D011720:Pyrazoles; D013449:Sulfonamides; D004008:Diclofenac; D000068579:Celecoxib; D009853:Omeprazole